In a research report published Thursday, Needham analyst Alan Carr reiterated a Hold rating on VIVUS, Inc. (NASDAQ:VVUS), as the company is expected to announce …
Brean Capital analyst Jonathan Aschoff reiterated a Sell rating on Vivus (NASDAQ:VVUS), while keeping his price target at $4, which represents a potential upside of 18% from …
